Novavax, Inc. (NVAX) Reports Q3 Loss of $0.03
Get Alerts NVAX Hot Sheet
Price: $3.95 --0%
EPS Growth %: +72.1%
Financial Fact:
Net loss: -66.25M
Today's EPS Names:
WF, CWBC, GLTO, More
EPS Growth %: +72.1%
Financial Fact:
Net loss: -66.25M
Today's EPS Names:
WF, CWBC, GLTO, More
Join SI Premium – FREE
Novavax, Inc. (NASDAQ: NVAX) reported Q3 EPS of ($0.03), $0.02 better than the analyst estimate of ($0.05). Revenue for the quarter came in at $5 million versus the consensus estimate of $5.37 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Alphabet stock surges 11% to record high on Q1 earnings beat, first-ever dividend
- Barnes Group (B) Tops Q1 EPS by 2c; Raises guidance
- Snap shares surge 26% on earnings beat, optimistic outlook
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!